Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Quick facts
Marketed products
- Alpha-lipoic acid · Metabolic / Endocrinology
Alpha-lipoic acid is an antioxidant that regenerates other antioxidants and modulates cellular energy metabolism by acting as a cofactor for mitochondrial enzyme complexes.
Phase 3 pipeline
- Silver Sulfadiazine Cream 1% · Dermatology
Silver sulfadiazine cream acts as a topical antibacterial agent, inhibiting bacterial growth and preventing infection in burns and wounds.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara portfolio CI brief
- Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara pipeline updates RSS
Frequently asked questions about Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
What are Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara's marketed drugs?
Top marketed products include Alpha-lipoic acid.
What is Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara's pipeline?
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Silver Sulfadiazine Cream 1%.
Related
- Alpha-lipoic acid · Metabolic / Endocrinology
- Sector hub: All tracked pharma companies